<?xml version="1.0" encoding="UTF-8"?>
<ref id="B93-pharmaceutics-10-00039">
 <label>93.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Seremeta</surname>
    <given-names>K.P.</given-names>
   </name>
   <name>
    <surname>Chiappetta</surname>
    <given-names>D.A.</given-names>
   </name>
   <name>
    <surname>Sosnik</surname>
    <given-names>A.</given-names>
   </name>
  </person-group>
  <article-title>Poly(ε-caprolactone), Eudragit
   <sup>®</sup> RS 100 and poly(ε-caprolactone)/Eudragit
   <sup>®</sup> RS 100 blend submicron particles for the sustained release of the antiretroviral efavirenz
  </article-title>
  <source>Colloids Surf. B Biointerfaces.</source>
  <year>2013</year>
  <volume>102</volume>
  <fpage>441</fpage>
  <lpage>449</lpage>
  <pub-id pub-id-type="doi">10.1016/j.colsurfb.2012.06.038</pub-id>
  <?supplied-pmid 23010128?>
  <pub-id pub-id-type="pmid">23010128</pub-id>
 </element-citation>
</ref>
